المؤلفون: Ziemssen, Tjalf, De Stefano, Nicola, SORMANI, MARIA PIA, Van Wijmeersch, Bart, Wiendl, Heinz, Kieseier, Bernd C.

المساهمون: Ziemssen, Tjalf, De Stefano, Nicola, Sormani, MARIA PIA, Van Wijmeersch, Bart, Wiendl, Heinz, Kieseier, Bernd C.

مصطلحات موضوعية: Breakthrough disease activity, MS therapie, Optimizing treatment, Outcome measure, Switching therapy, Treatment algorithm, Neurology (clinical), Neurology

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26346796; info:eu-repo/semantics/altIdentifier/wos/WOS:000362133000014; volume:4; firstpage:460; lastpage:469; numberofpages:10; journal:MULTIPLE SCLEROSIS AND RELATED DISORDERS; http://hdl.handle.net/11567/818148Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84941619481

الإتاحة: https://doi.org/10.1016/j.msard.2015.07.007Test
http://hdl.handle.net/11567/818148Test

المؤلفون: Cellerino M., Bonavita S., Ferrero M., Inglese M., Boffa G.

المساهمون: Cellerino, M., Bonavita, S., Ferrero, M., Inglese, M., Boffa, G.

مصطلحات موضوعية: Breakthrough disease activity, Cladribine, Fingolimod withdrawal, Multiple sclerosis

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33010653; info:eu-repo/semantics/altIdentifier/wos/WOS:000582930900061; volume:418; firstpage:117156; lastpage:N/A; numberofpages:1; journal:JOURNAL OF THE NEUROLOGICAL SCIENCES; https://hdl.handle.net/11567/1025291Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85091675173

الإتاحة: https://doi.org/10.1016/j.jns.2020.117156Test
https://hdl.handle.net/11567/1025291Test

المؤلفون: Maria Cellerino, Margherita Ferrero, Matilde Inglese, Giacomo Boffa, Simona Bonavita

المساهمون: Cellerino, M., Bonavita, S., Ferrero, M., Inglese, M., Boffa, G.

المصدر: Journal of the neurological sciences. 418

مصطلحات موضوعية: medicine.medical_specialty, Breakthrough disease activity, business.industry, Fingolimod Hydrochloride, Multiple sclerosis, Severe disease, Cladribine, Fingolimod withdrawal, medicine.disease, Fingolimod, Immunosuppressive Agent, Multiple Sclerosis, Relapsing-Remitting, Neurology, Internal medicine, medicine, Humans, Multiple sclerosi, Neurology (clinical), business, Immunosuppressive Agents, Human, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a05147b4d7459b9790bae766ccdb8e0Test
https://pubmed.ncbi.nlm.nih.gov/33010653Test

المؤلفون: Heinz Wiendl, Maria Pia Sormani, Bart Van Wijmeersch, Nicola De Stefano, Bernd C. Kieseier, Tjalf Ziemssen

المصدر: Multiple Sclerosis and Related Disorders. 4:460-469

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Pathology, Multiple Sclerosis, Time Factors, Evidence-based practice, Decision Making, Outcome measures, Switching therapy, Internal medicine, Breakthrough disease activity, MS therapies, Optimizing treatment, Treatment algorithm, Neurology (clinical), Neurology, medicine, Humans, Glatiramer acetate, Cognitive decline, Treatment Outcome, Evidence-Based Medicine, Medicine (all), medicine.diagnostic_test, business.industry, Multiple sclerosis, Neurodegeneration, Magnetic resonance imaging, General Medicine, Evidence-based medicine, medicine.disease, Pathology of multiple sclerosis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1bbb2f046d2f0e858779122eb145889Test
https://doi.org/10.1016/j.msard.2015.07.007Test